Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461.
Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY 10461.
Proc Natl Acad Sci U S A. 2024 Sep 17;121(38):e2322929121. doi: 10.1073/pnas.2322929121. Epub 2024 Sep 11.
Chaperone-mediated autophagy (CMA) is a selective form of autophagy that contributes to the maintenance of cellular homeostasis. CMA activity declines with age in most tissues and systems, including the immune system, due to a reduction in levels of lysosome-associated membrane protein type 2A (LAMP2A), an essential CMA component. In this study, we show that overexpressing a copy of hLAMP2A within T cells since middle-age can prevent some of their age-associated loss of function. Our data support the idea that preserving LAMP2A expression with age through genetic means leads to enhanced proliferative responses, decreased number of regulatory T cell populations, and down-regulated expression of inhibitory receptors by T cells. During aging, elevated numbers of these immunosuppressive T cell populations significantly contribute to the age-associated downregulation of T cell responses. Using comparative proteomics, we confirm that preservation of CMA activity in old mice prevents age-related changes in both the resting and the activated T cell proteome. We also explore the effect of using first-in-class small molecule activators of CMA and demonstrate improved T cell response upon their administration to old mice. We conclude that sustaining CMA activity constitutes a potentially viable therapeutic approach to improving T cell function with age.
伴侣蛋白介导的自噬(CMA)是一种选择性的自噬形式,有助于维持细胞内稳态。由于溶酶体相关膜蛋白 2A(LAMP2A)水平降低,大多数组织和系统(包括免疫系统)的 CMA 活性随着年龄的增长而下降,LAMP2A 是 CMA 的一个重要组成部分。在这项研究中,我们表明,从中年开始在 T 细胞中过表达 hLAMP2A 的副本可以防止它们与年龄相关的一些功能丧失。我们的数据支持这样一种观点,即通过遗传手段随着年龄的增长保留 LAMP2A 的表达会导致增强的增殖反应、调节性 T 细胞群体数量减少以及 T 细胞抑制性受体的下调。在衰老过程中,这些免疫抑制性 T 细胞群体数量的增加显著导致与年龄相关的 T 细胞反应下调。使用比较蛋白质组学,我们证实了在老年小鼠中保持 CMA 活性可以防止静息和激活的 T 细胞蛋白质组中与年龄相关的变化。我们还探讨了使用 CMA 的首创小分子激活剂的效果,并证明在将其施用于老年小鼠时改善了 T 细胞反应。我们得出结论,维持 CMA 活性是改善 T 细胞功能随年龄增长的一种潜在可行的治疗方法。